Cure My Disease

Don't miss your cure!

 Log in / Sign up

New stent combo aims to cut bleeding risk in High-Risk heart patients

NCT ID NCT05650411

Recruiting now Disease control Sponsor: IGLESIAS Juan Fernando Source: ClinicalTrials.gov ↗

First seen Jan 10, 2026 · Last updated Jun 16, 2026 · Updated 26 times

Summary

This study tests a new ultra-thin stent coated with a drug to keep arteries open, combined with a shorter course of two blood thinners (1-3 months) followed by just one blood thinner, in people with left main coronary artery disease. The goal is to see if this approach reduces major bleeding while still protecting against heart attacks and the need for repeat procedures. About 828 adults who have already received this stent will be randomly assigned to the shorter or standard 12-month dual antiplatelet therapy and followed for outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEFT MAIN CORONARY ARTERY STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Zurich University Hospital

    RECRUITING

    Zurich, Canton of Zurich, Switzerland

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.

LEFT MAIN CORONARY ARTERY STENOSIS